138 related articles for article (PubMed ID: 15730056)
1. Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate.
Freemont T; Malluche HH
Clin Nephrol; 2005 Feb; 63(2):138-45. PubMed ID: 15730056
[TBL] [Abstract][Full Text] [Related]
2. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.
Ferreira A; Frazão JM; Monier-Faugere MC; Gil C; Galvao J; Oliveira C; Baldaia J; Rodrigues I; Santos C; Ribeiro S; Hoenger RM; Duggal A; Malluche HH;
J Am Soc Nephrol; 2008 Feb; 19(2):405-12. PubMed ID: 18199805
[TBL] [Abstract][Full Text] [Related]
3. Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years.
Malluche HH; Siami GA; Swanepoel C; Wang GH; Mawad H; Confer S; Smith M; Pratt RD; Monier-Faugere MC;
Clin Nephrol; 2008 Oct; 70(4):284-95. PubMed ID: 18826853
[TBL] [Abstract][Full Text] [Related]
4. Effects of treatment of renal osteodystrophy on bone histology.
Malluche HH; Mawad H; Monier-Faugere MC
Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S157-63. PubMed ID: 18988701
[TBL] [Abstract][Full Text] [Related]
5. Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate.
Ballanti P; Coen G; Mazzaferro S; Taggi F; Giustini M; Calabria S; Ferrannini M; Bonucci E
Histopathology; 2001 Jun; 38(6):571-83. PubMed ID: 11422502
[TBL] [Abstract][Full Text] [Related]
6. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.
D'Haese PC; Spasovski GB; Sikole A; Hutchison A; Freemont TJ; Sulkova S; Swanepoel C; Pejanovic S; Djukanovic L; Balducci A; Coen G; Sulowicz W; Ferreira A; Torres A; Curic S; Popovic M; Dimkovic N; De Broe ME
Kidney Int Suppl; 2003 Jun; (85):S73-8. PubMed ID: 12753271
[TBL] [Abstract][Full Text] [Related]
7. The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease.
Freemont AJ; Hoyland JA; Denton J;
Clin Nephrol; 2005 Dec; 64(6):428-37. PubMed ID: 16370155
[TBL] [Abstract][Full Text] [Related]
8. Infrared spectroscopy indicates altered bone turnover and remodeling activity in renal osteodystrophy.
Isaksson H; Turunen MJ; Rieppo L; Saarakkala S; Tamminen IS; Rieppo J; Kröger H; Jurvelin JS
J Bone Miner Res; 2010 Jun; 25(6):1360-6. PubMed ID: 20200925
[TBL] [Abstract][Full Text] [Related]
9. Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia.
Shigematsu T; Tokumoto A; Nakaoka A; Arisaka H
Ther Apher Dial; 2011 Apr; 15(2):176-84. PubMed ID: 21426511
[TBL] [Abstract][Full Text] [Related]
10. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
[TBL] [Abstract][Full Text] [Related]
11. The relevance of mineralization lag time in the evaluation of histologic changes in renal osteodystrophy.
Libbey NP; Chazan JA; London MR; Pono L; Abuelo JG
Clin Nephrol; 1993 Apr; 39(4):214-23. PubMed ID: 8491052
[TBL] [Abstract][Full Text] [Related]
12. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
[TBL] [Abstract][Full Text] [Related]
13. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
[TBL] [Abstract][Full Text] [Related]
14. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up.
Spasovski GB; Sikole A; Gelev S; Masin-Spasovska J; Freemont T; Webster I; Gill M; Jones C; De Broe ME; D'Haese PC
Nephrol Dial Transplant; 2006 Aug; 21(8):2217-24. PubMed ID: 16595583
[TBL] [Abstract][Full Text] [Related]
15. Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings.
Malluche HH; Monier-Faugere MC
Clin Nephrol; 2006 Apr; 65(4):235-42. PubMed ID: 16629221
[TBL] [Abstract][Full Text] [Related]
16. Bone histomorphometry in renal osteodystrophy.
Ott SM
Semin Nephrol; 2009 Mar; 29(2):122-32. PubMed ID: 19371803
[TBL] [Abstract][Full Text] [Related]
17. Lanthanum carbonate stimulates bone formation in a rat model of renal insufficiency with low bone turnover.
Fumoto T; Ito M; Ikeda K
J Bone Miner Metab; 2014 Sep; 32(5):484-93. PubMed ID: 24126694
[TBL] [Abstract][Full Text] [Related]
18. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.
Parfitt AM
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):387-403. PubMed ID: 12815335
[TBL] [Abstract][Full Text] [Related]
19. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.
Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P
J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489
[TBL] [Abstract][Full Text] [Related]
20. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
